ARGATROBAN 250mg (Argatroban Vials) 250mg/2.5ml

Argatroban 250mg is an anticoagulant injection used to prevent blood clots in patients with heparin-induced thrombocytopenia. This sterile vial formulation provides precise dosing for hospital and clinical settings.

Strength

250mg/2.5ml

Pack Size

Storage

15-25°

Manufacturer / TM Owner

Mylan Institutional LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Argatroban 250mg is used to treat or prevent blood clots in adults who have developed heparin-induced thrombocytopenia, a serious immune response to heparin. It works by directly inhibiting thrombin, the enzyme responsible for blood clot formation. This medication is typically administered in a healthcare setting under medical supervision.

Side Effects

After administration, argatroban begins working within minutes to reduce the risk of clot formation. Patients may experience improved blood flow and reduced symptoms related to clotting disorders. Common effects include changes in blood pressure or heart rate, which are monitored during treatment.

Precautions & Warnings

Argatroban should only be handled and administered by trained healthcare professionals. It requires careful monitoring of blood clotting parameters during use. Patients with severe liver disease may need adjusted dosing. Always inform your healthcare provider about all medications and medical conditions before starting treatment.

Avoid Interactions

Argatroban may interact with other blood thinners, certain antibiotics, and medications that affect liver enzymes. Combining it with antiplatelet drugs can increase bleeding risk. Alcohol and herbal supplements like ginkgo biloba may also affect its action. Always discuss all medications with your doctor.

Frequently Asked Questions

Argatroban 250mg is used to treat or prevent blood clots in patients with heparin-induced thrombocytopenia.

It is given as an intravenous injection in a healthcare setting by trained professionals.

No, argatroban requires administration and monitoring in a clinical or hospital setting.

Common effects include changes in blood pressure, heart rate, and bleeding at the injection site.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.